Chronic inhibition of cyclic GMP phosphodiesterase 5A prevents and reverses cardiac hypertrophy
Data up to Jan 2025
Total Citations Per Year
Abstract
References (52)
A Calcineurin-Dependent Transcriptional Pathway for Cardiac Hypertrophy
1998 • 2,570 citations
Oral Sildenafil in the Treatment of Erectile Dysfunction
1998 • 2,097 citations
Cardiac Hypertrophy: The Good, the Bad, and the Ugly
2003 • 1,410 citations
Glycogen synthase kinase-3β mediates convergence of protection signaling to inhibit the mitochondrial permeability transition pore
2004 • 979 citations
Hypertrophy of the Heart
2004 • 817 citations
The MEK1-ERK1/2 signaling pathway promotes compensated cardiac hypertrophy in transgenic mice
2000 • 778 citations
Calcineurin/NFAT Coupling Participates in Pathological, but not Physiological, Cardiac Hypertrophy
2003 • 746 citations
Regulation of Myocardial Contractility and Cell Size by Distinct PI3K-PTEN Signaling Pathways
2002 • 584 citations
Hypertension, cardiac hypertrophy, and sudden death in mice lacking natriuretic peptide receptor A
1997 • 569 citations
Cyclic nucleotide phosphodiesterases: Relating structure and function
2000 • 565 citations
Nitric Oxide and Cardiac Function
2003 • 554 citations
Cyclic GMP Phosphodiesterases and Regulation of Smooth Muscle Function
2003 • 499 citations
Clinical efficacy of sildenafil in primary pulmonary hypertension
2004 • 488 citations
The role of phosphoinositide-3 kinase and PTEN in cardiovascular physiology and disease
2004 • 468 citations
Activated glycogen synthase-3β suppresses cardiac hypertrophy in vivo
2002 • 467 citations
PI3Kγ Modulates the Cardiac Response to Chronic Pressure Overload by Distinct Kinase-Dependent and -Independent Effects
2004 • 460 citations
Akt induces enhanced myocardial contractility and cell size in vivo in transgenic mice
2002 • 455 citations
Phenotypic Spectrum Caused by Transgenic Overexpression of Activated Akt in the Heart
2002 • 438 citations
Glycogen Synthase Kinase-3β
2002 • 435 citations
Oral sildenafil in the treatment of erectile dysfunction
2002 • 406 citations
Pharmacokinetics and metabolism of sildenafil in mouse, rat, rabbit, dog and man
1999 • 397 citations
Involvement of Extracellular Signal-Regulated Kinases 1/2 in Cardiac Hypertrophy and Cell Death
2002 • 387 citations
Genetic Alterations That Inhibit In Vivo Pressure-Overload Hypertrophy Prevent Cardiac Dysfunction Despite Increased Wall Stress
2002 • 375 citations
Pressure-independent cardiac hypertrophy in mice with cardiomyocyte-restricted inactivation of the atrial natriuretic peptide receptor guanylyl cyclase-A
2003 • 335 citations
Pressure-independent enhancement of cardiac hypertrophy in natriuretic peptide receptor A–deficient mice
2001 • 305 citations
Mitochondrial ATP-Sensitive Potassium Channels Inhibit Apoptosis Induced by Oxidative Stress in Cardiac Cells
2001 • 281 citations
Regulation of Gene Expression by Cyclic GMP
2003 • 276 citations
Inhibition of calcineurin-NFAT hypertrophy signaling by cGMP-dependent protein kinase type I in cardiac myocytes
2002 • 274 citations
A genetic model provides evidence that the receptor for atrial natriuretic peptide (guanylyl cyclase-A) inhibits cardiac ventricular myocyte hypertrophy
2001 • 270 citations
Impaired cardiac hypertrophic response in Calcineurin Aβ -deficient mice
2002 • 240 citations
PDE5 is converted to an activated state upon cGMP binding to the GAF A domain
2003 • 233 citations
Calcineurin Promotes Protein Kinase C and c-Jun NH2-terminal Kinase Activation in the Heart
2000 • 232 citations
Cardiac phosphodiesterase 5 (cGMP‐specific) modulates β‐adrenergic signaling in vivo and is down‐regulated in heart failure
2001 • 228 citations
Calcineurin-Mediated Hypertrophy Protects Cardiomyocytes From Apoptosis In Vitro and In Vivo
2000 • 228 citations
cGMP Catabolism by Phosphodiesterase 5A Regulates Cardiac Adrenergic Stimulation by NOS3-Dependent Mechanism
2004 • 211 citations
Upregulation of Phosphodiesterase 1A1 Expression Is Associated With the Development of Nitrate Tolerance
2001 • 193 citations
Akt and PI 3-Kinase Signaling in Cardiomyocyte Hypertrophy and Survival
2003 • 185 citations
Therapeutic Potential of Phosphodiesterase 5 Inhibition for Cardiovascular Disease
2003 • 154 citations
Isoproterenol Activates Extracellular Signal–Regulated Protein Kinases in Cardiomyocytes Through Calcineurin
2001 • 137 citations
Gene Transfer of cGMP-Dependent Protein Kinase I Enhances the Antihypertrophic Effects of Nitric Oxide in Cardiomyocytes
2002 • 136 citations
Glycogen Synthase Kinase-3β Regulates Growth, Calcium Homeostasis, and Diastolic Function in the Heart
2004 • 125 citations
A-Kinase Anchoring Protein AKAP220 Binds to Glycogen Synthase Kinase-3β (GSK-3β) and Mediates Protein Kinase A-dependent Inhibition of GSK-3β
2002 • 125 citations
MEKK1 is essential for cardiac hypertrophy and dysfunction induced by Gq
2002 • 100 citations
Phosphorylation of Isolated Human Phosphodiesterase-5 Regulatory Domain Induces an Apparent Conformational Change and Increases cGMP Binding Affinity
2002 • 93 citations
Expression of Constitutively Active Guanylate Cyclase in Cardiomyocytes Inhibits the Hypertrophic Effects of Isoproterenol and Aortic Constriction on Mouse Hearts
2003 • 86 citations
Modulation of In Vivo Cardiac Function by Myocyte-Specific Nitric Oxide Synthase-3
2004 • 80 citations
Sildenafil citrate does not affect cardiac contractility in human or dog heart
2003 • 64 citations
Time-dependent systolic and diastolic function in mice overexpressing calcineurin
2003 • 39 citations
cGMP-dependent protein kinase protects cGMP from hydrolysis by phosphodiesterase-5
2003 • 38 citations
Increased Activity of cGMP-Specific Phosphodiesterase (PDE5) Contributes to Resistance to Atrial Natriuretic Peptide Natriuresis in the Pregnant Rat
2004 • 29 citations
Phosphorylation of glycogen synthase kinase-3β at serine-9 by phospholipase Cγ1 through protein kinase C in rat 3Y1 fibroblasts
2002 • 19 citations
The Good, the Bad, and the Ugly
2003 • 14 citations